Summit Therapeutics Inc. (SMMT)
NASDAQ: SMMT · Real-Time Price · USD
24.56
-1.66 (-6.33%)
At close: Sep 18, 2024, 4:00 PM
24.74
+0.18 (0.75%)
After-hours: Sep 18, 2024, 7:58 PM EDT
Summit Therapeutics Market Cap
Summit Therapeutics has a market cap or net worth of $18.05 billion as of September 18, 2024. Its market cap has increased by 1,487.14% in one year.
Market Cap
18.05B
Enterprise Value
19.05B
1-Year Change
1,487.14%
Ranking
Category
Stock Price
$24.56
Market Cap Chart
Since March 5, 2015, Summit Therapeutics's market cap has increased from $119.00M to $18.05B, an increase of 15,067.15%. That is a compound annual growth rate of 69.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Sep 17, 2024 | 19.00B | 938.56% |
| Dec 29, 2023 | 1.83B | 113.79% |
| Dec 30, 2022 | 855.60M | 225.45% |
| Dec 31, 2021 | 262.90M | -32.00% |
| Dec 31, 2020 | 386.60M | 653.61% |
| Dec 31, 2019 | 51.30M | 203.55% |
| Dec 31, 2018 | 16.90M | -87.66% |
| Dec 29, 2017 | 137.00M | 30.60% |
| Dec 30, 2016 | 104.90M | -21.83% |
| Dec 31, 2015 | 134.20M | 12.77% |
| Mar 5, 2015 | 119.00M | - |
View and export this data all the way back to 2015.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Illumina | 20.72B |
| Baxter International | 20.46B |
| Teva Pharmaceutical | 20.10B |
| Waters | 19.57B |
| Align Technology | 19.30B |
| Hologic | 19.20B |
| Labcorp Holdings | 19.19B |
| Avantor | 18.58B |